Table 5 Transplant-related complications in ATG and non-ATG groups.
Complications | Non-ATG group No. (%) | ATG group No. (%) | χ2 | P-value |
|---|---|---|---|---|
Relapse | 0.036 | 0.85 | ||
Yes | 9 (19.6) | 7 (17.9) | ||
No | 37 (80.4) | 32 (82.1) | ||
NRM | 4.71 | 0.03 | ||
Yes | 21 (45.7) | 9 (23.1) | ||
No | 25 (54.3) | 30 (76.9) | ||
aGVHD | 1.80 | 0.18 | ||
Yes | 25 (62.5) | 18 (47.4) | ||
No | 15 (37.5) | 20 (52.6) | ||
cGVHD | 0.37 | 0.54 | ||
Yes | 19 (55.9) | 16 (48.5) | ||
No | 15 (44.1) | 17 (51.5) | ||
Infection | 1.05 | 0.31 | ||
Yes | 25 (60) | 27 (71.1) | ||
No | 15 (40) | 11 (28.9) | ||
EBV | 8.53 | 0.003 | ||
Yes | 3 (7.5) | 13 (34.2) | ||
No | 37 (92.5) | 25 (65.8) | ||
CMV | 4.24 | 0.04 | ||
Yes | 10 (25) | 18 (47.4) | ||
No | 30 (75) | 20 (52.6) | ||
HC | 0.43 | 0.52 | ||
Yes | 9 (22.5) | 11 (28.9) | ||
No | 31 (77.5) | 27 (71.1) |
